Literature DB >> 26891397

Transforaminal Epidural Steroid Injections for Treating Lumbosacral Radicular Pain from Herniated Intervertebral Discs: A Systematic Review and Meta-Analysis.

Anuj Bhatia1, David Flamer, Prakesh S Shah, Steven P Cohen.   

Abstract

BACKGROUND: Steroids often are administered into the epidural space through the transforaminal epidural (TFE) route to treat lumbosacral radicular pain secondary to herniated intervertebral discs. However, their efficacy and safety compared with transforaminal epidural local anesthetics (LAs) or saline injections is unclear.
METHODS: We reviewed randomized controlled trials that compared TFE injections of steroids (with or without LA) with LA or saline in adult outpatients with lumbosacral radicular pain secondary to herniated intervertebral disks. Databases searched included MEDLINE, EMBASE, Cochrane central register of controlled trials, Cochrane database of systematic reviews, and Google Scholar up to February 2015. Data on scores of numerical rating scale for pain, validated scores for measuring physical disability and quality of life, and incidence of surgery measured at 1 month to 2 years after the interventions were meta-analyzed. Strength of evidence was classified with the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system.
RESULTS: Eight randomized controlled trials including 771 patients (366 in steroid and 405 in comparator groups) were included. There was variability in the studies in the dose of TFE steroids, frequency, and number of procedures. Patients who received TFE steroids reported a significant, but clinically modest, reduction in mean pain scores (0-10 scale) compared with LA/saline (-0.97 points; 95% confidence interval, -1.42 to -0.51 points; P < 0.0001, I² = 90%; GRADE weak recommendation; moderate-quality evidence) at 3 months after the interventions. TFE steroids did not decrease physical disability at 1 to 3 months after the intervention (GRADE strong recommendation ↓; high-quality evidence) or incidence of surgery at 12 months after the intervention (GRADE strong recommendation ↓; moderate-quality evidence) compared with LA/saline.
CONCLUSIONS: TFE steroids provide modest analgesic benefit at 3 months in patients with lumbosacral radicular pain secondary to herniated intervertebral disks, but they have no impact on physical disability or incidence of surgery. There was a high degree of heterogeneity among the publications included in this meta-analysis. Well-designed, large, randomized studies are required to evaluate appropriate dosages, adverse effects, number of procedures, and the effect of this intervention on psychological disability and quality of life.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26891397     DOI: 10.1213/ANE.0000000000001155

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  31 in total

1.  Quantitative sensory testing to evaluate and compare the results after epidural injection and simple discectomy, in patients with radiculopathy secondary to lumbar disc herniation.

Authors:  Irene Garcia-Saiz; Enrique M San Norberto; Eduardo Tamayo; Enrique Ortega; Cesar Aldecoa
Journal:  J Clin Monit Comput       Date:  2019-09-26       Impact factor: 2.502

Review 2.  [Background and current use of adjuvants for regional anesthesia : From research to evidence-based patient treatment].

Authors:  M Schäfer; S A Mousa; M Shaqura; S Tafelski
Journal:  Anaesthesist       Date:  2019-01       Impact factor: 1.041

3.  Curcumin alleviates lumbar radiculopathy by reducing neuroinflammation, oxidative stress and nociceptive factors.

Authors:  L Xiao; M Ding; A Fernandez; P Zhao; L Jin; X Li
Journal:  Eur Cell Mater       Date:  2017-05-09       Impact factor: 3.942

4.  Long-term effectiveness of epidural steroid injections after new episodes of low back pain in older adults.

Authors:  Michele Curatolo; Sean D Rundell; Laura S Gold; P Suri; Janna L Friedly; Sdrj S Nedeljkovic; Richard A Deyo; Judith A Turner; Brian W Bresnahan; Andrew L Avins; Larry Kessler; Patrick J Heagerty; Jeffrey G Jarvik
Journal:  Eur J Pain       Date:  2022-05-29       Impact factor: 3.651

5.  Relationship between needle depth for lumbar transforaminal epidural injection and patients' height and weight using magnetic resonance imaging.

Authors:  Hyunji John; Kyomin Sohn; Jae Hun Kim
Journal:  Korean J Pain       Date:  2022-07-01

6.  Hydroxylated Fullerene: A Stellar Nanomedicine to Treat Lumbar Radiculopathy via Antagonizing TNF-α-Induced Ion Channel Activation, Calcium Signaling, and Neuropeptide Production.

Authors:  Li Xiao; Kwangseok Hong; Charles Roberson; Mengmeng Ding; Andrew Fernandez; Francis Shen; Li Jin; Swapnil Sonkusare; Xudong Li
Journal:  ACS Biomater Sci Eng       Date:  2017-12-07

Review 7.  A scoping review of perineural steroids for the treatment of chronic postoperative inguinal pain.

Authors:  J S Khan; A Rai; R Sundara Rajan; T D Jackson; A Bhatia
Journal:  Hernia       Date:  2016-03-31       Impact factor: 4.739

8.  Epidural corticosteroid injections for lumbosacral radicular pain.

Authors:  Crystian B Oliveira; Christopher G Maher; Manuela L Ferreira; Mark J Hancock; Vinicius Cunha Oliveira; Andrew J McLachlan; Bart W Koes; Paulo H Ferreira; Steven P Cohen; Rafael Zambelli Pinto
Journal:  Cochrane Database Syst Rev       Date:  2020-04-09

9.  Clinical Relevance of Epidural Steroid Injections on Lumbosacral Radicular Syndrome-related Synptoms: Systematic Review and Meta-Analysis.

Authors:  Thomas M de Bruijn; Ingrid B de Groot; Harald S Miedema; Johan Haumann; Raymond W J G Ostelo
Journal:  Clin J Pain       Date:  2021-07-01       Impact factor: 3.442

10.  Analgesic effect of perineural local anesthetics, steroids, and conventional medical management for trauma and compression-related peripheral neuropathic pain: a retrospective cohort study.

Authors:  Anuj Bhatia; Vera Bril; Richard T Brull; Anthony V Perruccio; Duminda N Wijeysundera; Johnny Lau; Rajiv Gandhi; Nizar Mahomed; Aileen M Davis
Journal:  Pain Rep       Date:  2021-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.